![MV100040: Tris-GalNAc-β-Ala-PEG4-DBCO Pack Size:1 mg 5-Trihydroxy-6-[4-(2-hydroxy-3-isopropylamino-propoxy)-naphthalen-1-yloxy]-tetrahydro-pyran-2-carboxylic acid](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/MV100040.svg?v=1718828612)
Pay in 4 interest-free payments of $112.50 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
5-Trihydroxy-6-[4-(2-hydroxy-3-isopropylamino-propoxy)-naphthalen-1-yloxy]-tetrahydro-pyran-2-carboxylic acid
(β-D-GalNAc-sp)3-NHC(O)-PEG5-NHS Ester
62 / An Fmoc-protected L-serine building block carrying a β-D-glucose residue
57 / / Abiraterone-N-Oxide Sulfate / (3β)-17-(3-Pyridinyl)androsta-5
MV100040: Tris-GalNAc-β-Ala-PEG4-DBCO Pack Size:1 mg 5-Trihydroxy-6-[4-(2-hydroxy-3-isopropylamino-propoxy)-naphthalen-1-yloxy]-tetrahydro-pyran-2-carboxylic acidC94H149N13O35 2021. 25 A triantennary N acetylgalactosamine (Tri GalNAc) ligand presenting three GalNAc residues on a tris based branched scaffold, extended through a alanine linker and a discrete tetraethylene glycol (PEG4) spacer to a terminal dibenzocyclooctyne (DBCO) handle. The DBCO group reacts with azide functionalized partners via copper free strain promoted azide alkyne cycloaddition (SPAAC), forming stable 1,2,3 triazole linkages without a
US$ 325.00
US$ 35.00
US$ 30.00
US$ 34.00
US$ 59.00
US$ 35.00
US$ 110.00
